The device was first recalled in 2022, but a new software update has now been released that addresses the issue. The FDA wanted a new recall to be issued to ensure all customers went through with the update.

Peter Libby, MD, a cardiovascular medicine specialist with Brigham and Women’s Hospital, discussed the cases of AFib being seen in long-COVID patients.

In March of 2022, 177Lu-PSMA-617 was approved by the U.S. Food and Drug Administration for the treatment of metastatic castration-resistant prostate cancer in men with PSMA-avid disease who have previously undergone chemotherapy and a novel androgen receptor-directed therapy. 

Researchers are still working to determine if gum disease leads to heart rhythm issues or if is actually the other way around. 

A record-breaking 16.3 million people signed up for health insurance coverage on the Affordable Care Act marketplace during the latest open enrollment period.

Radiomics features could be especially useful for determining TSS in scenarios where clinical data is lacking or unreliable, such as when patients have altered mental status.

While a previous study had found that extracorporeal CPR outperformed conventional CPR among patients with out-of-hospital cardiac arrest, a newer analysis suggests the two treatment options result in similar outcomes. 

The device, designed to be worn for up to 24 hours at a time, uses ultrasound technology and artificial intelligence to track how much blood the user's heart is pumping.